Updated March 2 at 7:02pm
Biotechnology
44 results total, viewing 21 - 30
Nabsys Inc. has named Tony Shuber vice president and chief scientific officer in its latest move toward bringing its genome-mapping products to market. more
Global biotech firm Covidien PLC reported Friday that its net income rose five-tenths of a percent in its fiscal second quarter, totaling $441 million, or 97 cents per diluted share, compared with $439 million, or 92 cents per diluted share, during the same period a year earlier. more
MultiCell Technologies Inc. has been issued a U.S. patent for drug compositions and platform technologies, which are designed treat virus infections and cancer. more
Medtronic Inc., the second-largest maker of medical devices, agreed to buy Covidien PLC for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages. more
The Champlin Foundations awarded the University of Rhode Island three grants totaling $421,795 to purchase high-tech equipment to advance education and student learning. more
Nabsys Inc. has begun a search for CEO candidates with experience in life sciences commercialization, as the company moves closer to bringing its high-speed DNA sequencing technology to market, current CEO Dr. Barrett Bready told Providence Business News. more
The recent change in leadership at IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, reflects its changing direction, according to those familiar with the company. more
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the four winners of its second annual Rhode Island Bioscience Awards. more
An investor in two large Bay State health care companies involved in separate mergers said he doesn’t expect the U.S. Treasury’s recently announced measures aimed at cracking down on corporate tax inversions to derail those plans, the Boston Business Journal reported. more
The Spectranetics Corp. will acquire Covidien PLC’s Stellarex drug-coated angioplasty balloon platform for $30 million. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »